Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Multiple myeloma (MM) is an aggressive, incurable blood cancer characterized by relapse and remission cycles.
• Proteasome inhibitors (PIs) have significantly improved survival rates for MM patients.
• The proteasome, central to the ubiquitin-proteasome system (UPS), regulates critical cellular functions.

Purpose of the Study:

• To review recent evidence on natural compounds that inhibit proteasome activity.
• To explore the potential of these natural agents as novel anti-MM therapeutics.

Main Methods:

• Literature review of recent scientific evidence.
• Focus on natural compounds demonstrating proteasome inhibitory activity.
• Analysis of compounds with potential anti-multiple myeloma effects.

Main Results:

• Several natural compounds have been identified as proteasome inhibitors.
• These natural agents exhibit anti-MM activity by targeting the proteasome.
• Emerging evidence suggests natural compounds as a potential new drug source for MM.

Conclusions:

• Natural compounds offer a promising alternative or complementary strategy for MM treatment.
• Further research into proteasome-inhibiting natural agents could lead to novel therapies.
• Targeting the proteasome with natural compounds represents a significant area for anti-MM drug discovery.